<description>&lt;p&gt;Harry Destecroix was studying for his PhD at Bristol University when he co-founded Ziylo. Based on 20 years of Bristol chemistry research, the spin-out company created a new technology that can be developed to treat diabetes more effectively.  It's a breakthrough that led to its acquisition by pharmaceutical firm, Novo Nordisk, in a deal reportedly worth up to 600 million pounds.  Harry has also founded the incubator, Science Creates and is the founding managing partner of SCVC, a venture capital firm.   Harry tells Evan Davis why his own experience of spinning out a company has made him passionate to help other early-stage companies in the Bristol area – whether that’s providing lab space, finance or advice.&lt;/p&gt;&lt;p&gt;(Image: Harry Destecroix Credit: Peter Schiazza, Copyright: Science Creates)&lt;/p&gt;</description>

Harry Destecroix on spinning out a company from Bristol university and making millions

<p>Harry Destecroix was studying for his PhD at Bristol University when he co-founded Ziylo. Based on 20 years of Bristol chemistry research, the spin-out company created a new technology that can be developed to treat diabetes more effectively.  It's a breakthrough that led to its acquisition by pharmaceutical firm, Novo Nordisk, in a deal reportedly worth up to 600 million pounds.  Harry has also founded the incubator, Science Creates and is the founding managing partner of SCVC, a venture capital firm.   Harry tells Evan Davis why his own experience of spinning out a company has made him passionate to help other early-stage companies in the Bristol area – whether that’s providing lab space, finance or advice.</p><p>(Image: Harry Destecroix Credit: Peter Schiazza, Copyright: Science Creates)</p>

The Bottom Line

The Decisions That Made Me: Harry Destecroix (Ziylo, Science Creates, SCVC)

The Decisions That Made Me: Harry Destecroix (Ziylo, Science Creates, SCVC)

Description